# EDGAR Filing Document

**Accession Number:** 0001661600
**File Stem:** 0001683168-26-003867
**Filing Date:** 2026-5
**Character Count:** 81867
**Document Hash:** 40e2a8a2bdf655926020d4a3239b7bb4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-26-003867.hdr.sgml**: 20260514

**ACCESSION NUMBER**: 0001683168-26-003867

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 53

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260514

**DATE AS OF CHANGE**: 20260514

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SATIVUS TECH CORP.
- **CENTRAL INDEX KEY:** 0001661600
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 472847446
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-208814
- **FILM NUMBER:** 26976581

**BUSINESS ADDRESS:**
- **STREET 1:** #3 BETHESDA METRO CENTER #700
- **CITY:** BETHESDA
- **STATE:** MD
- **ZIP:** 06880
- **BUSINESS PHONE:** 800-608-6432

**MAIL ADDRESS:**
- **STREET 1:** #3 BETHESDA METRO CENTER #700
- **CITY:** BETHESDA
- **STATE:** MD
- **ZIP:** 06880

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SEEDO CORP.
- **DATE OF NAME CHANGE:** 20181106

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GRCR Partners Inc
- **DATE OF NAME CHANGE:** 20151221

?xml version='1.0' encoding='ASCII'? SATIVUS TECH CORP. 10-Q

[**Table of Contents**](#q1_001)

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

**FORM 10-Q**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

for the quarterly period ended **<u>March 31, 2026</u>**

OR

☐ **TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the period from <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> .**

Commission file number: 333-208814

**SATIVUS TECH CORP.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **47-2847446** |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
| **#3 Bethesda Metro Center, #700**<br> **Bethesda, MD**  | **20814** |
| (Address of principal executive offices) | (Zip Code) |

---

800 608-6432

Registrant's telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| NA | NA | NA |

---

Indicate by check mark whether the registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 day. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☐ No ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 if the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May 8, 2026, the registrant had 4,215,571 shares of its Common Stock, $0.001 par value, outstanding.

When used in this quarterly report, the terms "Sativus Tech Corp." "the Company," "we," "our," and "us" refer to Sativus Tech Corp.

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| PART I. | [FINANCIAL INFORMATION](#q1_002) | 3 |
| ITEM 1. | [CONDENSED CONSOLIDATED FINANCIAL STATEMENTS](#q1_003) | 3 |
| ITEM 1C. | [CYBER SECURITY](#q1_016) | 23 |
| ITEM 2. | [MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS](#q1_009) | 24 |
| ITEM 3. | [QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK](#q1_010) | 28 |
| ITEM 4. | [CONTROLS AND PROCEDURES](#q1_011) | 28 |
| PART II | [OTHER INFORMATION](#q1_012) | 29 |
| ITEM 5. | [OTHER INFORMATION](#q1_013) | 29 |
| ITEM 6. | [EXHIBITS](#q1_014) | 29 |
| [SIGNATURES](#q1_015) | [SIGNATURES](#q1_015) | 30 |

---

**PART I. FINANCIAL INFORMATION**

**Item 1. Condensed Consolidated Financial Statements**

**SATIVUS TECH CORP.**

**CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**As of March 31, 2026**

**IN THOUSANDS OF U.S. DOLLARS**

**INDEX**

---

| | |
|:---|:---|
|  | **Page** |
| [Condensed Consolidated Balance Sheets as of March 31, 2026 (unaudited) and December 31, 2025](#q1_004) | 4 |
| [Condensed Consolidated Statements of Comprehensive Loss for the Three Months Ended March 31, 2026 (unaudited) and 2025](#q1_005) | 5 |
| [Condensed Consolidated Statements of Changes in Shareholders' Deficit for the Three Months Ended March 31, 2026 (unaudited) and 2025 (unaudited)](#q1_006) | 6 |
| [Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2026 (unaudited) and 2025 (unaudited)](#q1_007) | 7 |
| [Notes to Unaudited Consolidated Financial Statements](#q1_008) | 8 |

---

**SATIVUS TECH CORP.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

**U.S. dollars in thousands, except share and per share data**

---

| | | |
|:---|:---|:---|
|  | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
|  | (Unaudited) | (Audited) |
| ASSETS |  |  |
| CURRENT ASSETS: |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $– | $32 |
| &nbsp;&nbsp;&nbsp;Restricted cash | 7 | 9 |
| &nbsp;&nbsp;&nbsp;Accounts receivable | 4 | 21 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other receivables | 7 | 41 |
| Total current assets | 18 | 103 |
| NON-CURRENT ASSETS |  |  |
| &nbsp;&nbsp;&nbsp;Property and equipment, net | 187 | 204 |
| Total non-current assets | 187 | 204 |
| Total assets | $205 | $307 |
| LIABILITIES AND SHAREHOLDERS' DEFICIT |  |  |
| CURRENT LIABILITIES |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payables | $283 | $267 |
| &nbsp;&nbsp;&nbsp;Convertible loans | 2492 | 2451 |
| &nbsp;&nbsp;&nbsp;Loans from related party | 137 | 98 |
| &nbsp;&nbsp;&nbsp;Fair value of convertible component in convertible loans | 786 | 726 |
| &nbsp;&nbsp;&nbsp;Other accounts liabilities | 290 | 296 |
| Total current liabilities | 3988 | 3838 |
| SHAREHOLDER'S DEFICIT |  |  |
| &nbsp;&nbsp;&nbsp;Ordinary shares of $0.0001 par value |  |  |
| &nbsp;&nbsp;&nbsp;Ordinary shares of $0.0001 par value Authorized: 500,000,000 shares at March 31, 2026 and December 31, 2025; Issued and Outstanding: 4,215,571 and 4,215,571 shares at March 31, 2026 and December 31, 2025, respectively | 4 | 4 |
| &nbsp;&nbsp;&nbsp;Additional Paid in capital | 20973 | 20973 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (24672) | (24477) |
| **Shareholders' deficit** | (3695) | (3500) |
| &nbsp;&nbsp;&nbsp;Non-controlling interests | (88) | (31) |
| Total shareholders' deficit | (3783) | (3531) |
| Total liabilities and shareholders' deficit | $205 | $307 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

**SATIVUS TECH CORP.**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)** (Unaudited)

**U.S. dollars in thousands, except share and per share data**

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Operating expenses: |  |  |
| Research and development | $(77) | $(206) |
| General and administrative | (71) | (54) |
| Operating loss | (148) | (260) |
| Financial Income (expenses), net | (104) | 162 |
| Net loss | (252) | (98) |
| Non-controlling interests | (57) | (97) |
| Net loss attributable to equity holders of the Company | $(195) | $(1) |
| Basic and diluted net loss per share attributable to equity holders of the Company | $(0.05) | $(0.00) |
| Weighted average number of ordinary shares used in computing basic and diluted loss per share | 4215571 | 4215571 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

**SATIVUS TECH CORP.**

**CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT**

**U.S. dollars in thousands, except share and per share data**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Ordinary shares** | **Ordinary shares** | | | | | |
|  | **Number** | **Amount** | **Additional Paid in**<br>**capital** | **Accumulated**<br>**Deficit** | **Total Shareholders'**<br>**Deficiency** | **Non-<br> Controlling**<br>**Interests** |<br>**Total** |
| Balance as of January 1, 2026 | 4215571 | $4 | $20973 | $(24477) | $(3500) | $(31) | $(3531) |
| Net Loss | – | – | – | (195) | (195) | (57) | (252) |
| Balance as of March 31, 2026 (Unaudited) | 4215571 | $4 | $20973 | $(24672) | $(3695) | $(88) | $(3783) |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Ordinary shares** | **Ordinary shares** | | | | | |
|  | **Number** | **Amount** | **Additional Paid in**<br>**Capital** | **Accumulated**<br>**Deficit** | **Total Shareholders'**<br>**Deficiency** | **Non-<br> controlling**<br>**Interests** |<br>**Total** |
| Balance as of January 1, 2025 | 4215571 | $4 | $20683 | $(23608) | $(2921) | $251 | $(2670) |
| Share Based Compensation to employees and non-employees |  |  | 11 |  | 11 | 7 | 18 |
| Net income | – | – | – | (1) | (1) | (97) | (98) |
| Balance as of March 31, 2025 (Unaudited) | 4215571 | $4 | $20694 | $(23609) | $(2911) | $161 | $(2750) |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

**SATIVUS TECH CORP.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** (Unaudited)

**U.S. dollars in thousands**

---

| | | |
|:---|:---|:---|
|  | **Three months ended** | **Three months ended** |
|  | **March 31,** | **March 31,** |
|  | **2026** | **2025** |
| <u>Cash flows from operating activities:</u> |  |  |
| &nbsp;&nbsp;&nbsp;Net income (loss) | $(252) | $(98) |
| Adjustments to reconcile loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 17 | 95 |
| &nbsp;&nbsp;&nbsp;Share based compensation expenses to employees and non-employees |  |  |
| &nbsp;&nbsp;&nbsp;Financial expenses related to convertible loans and warrants | 41 | 42 |
| &nbsp;&nbsp;&nbsp;Change in fair value of convertible component in convertible loans | 60 | (203) |
| <u>Changes in assets and liabilities:</u> |  |  |
| &nbsp;&nbsp;&nbsp;Decrease (Increase) in other accounts receivable | 34 | 12 |
| &nbsp;&nbsp;&nbsp;Increase in accounts receivable | 17 | (12) |
| &nbsp;&nbsp;&nbsp;Decrease (Increase) in trade payables | 16 | (12) |
| &nbsp;&nbsp;&nbsp;Decrease (Increase) in other accounts payables | (6) | 26 |
| Net cash used in operating activities | (73) | (150) |
| <u>Cash flows from investing activities:</u> |  |  |
| &nbsp;&nbsp;&nbsp;Decrease (increase) in restricted cash | 2 | 6 |
| Net cash used in investing activities | 2 | 6 |
| <u>Cash flows from financing activities:</u> |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds Loans from related party | 39 | 26 |
| &nbsp;&nbsp;&nbsp;Proceeds from convertible loan |  | 36 |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of shares to minority interests in subsidiary | – | 18 |
| Net cash provided (used) by financing activities | 39 | 80 |
| Increase (decrease) in cash and cash equivalents and restricted cash | (32) | (64) |
| Cash and cash equivalents and restricted cash at the beginning of the year | 32 | 96 |
| Cash and cash equivalents at the end of the period | $– | $32 |
| <u>Supplemental disclosures of cash flow information:</u> |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid for interest | $– | $– |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

---

| |
|:---|
| **SATIVUS TECH CORP**. |
| **NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** (Unaudited) |
| **U.S. dollars in thousands** |

---

---

| | |
|:---|:---|
| **NOTE 1:** | **GENERAL** |

---

---

| | |
|:---|:---|
| a. | SATIVUS TECH CORP. (formerly SEEDO CORP.) (the "Company", "Our" or "We") was formed on January 16, 2015, under the laws of the State of Delaware. Prior to July 2020, we were involved in producing a plant growing device managed and controlled by an artificial intelligent algorithm, allowing consumers to grow their own herbs and vegetables effortlessly from seed to plant, while providing optimal conditions to assure premium quality produce year-round. However, due to financial and operational difficulties and during 2020, we ceased these operations and on July 19, 2020, the Company formed a new wholly-owned subsidiary in Israel, Hachevra Legiduley Pkaot Beisrael Ltd. (the "New Subsidiary"), to develop a fully automated and remotely managed system for growing saffron and other vegetables. On November 5, 2020, the New Subsidiary changed its name to Saffron-Tech Ltd. (or "Saffron Tech"). As of the date of this report, and following various financings in Saffron Tech, the Company owns 54% of Saffron Tech. |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Company, through Saffron Tech, is focusing on its in-house research and development of agriculture technology products, among others, in the fields of exotic plants and mushrooms. Saffron Tech plans to roll out its proof of concept in the coming months. This technology will provide turnkey automated growing containers for high-quality, high-yield saffron all year round. The Company is in advanced stages of developing and testing a fully automated and remotely managed system for growing high-quality, high-yield saffron anywhere and anytime.<br>It is also environmentally friendly, using economic levels of water, space, fertilizer, and energy. Accounting to the Company's calculations, we believe that the controlled indoor growing area will produce ten times more yield compared to the same land area using traditional methods. The sealed environment eliminates the need for harmful pesticides and herbicides, producing a clean and safe product that is easy to control from anywhere. The Company's solution is easily scalable and pre-designed to quickly grow operations.<br>Saffron is used in many industries, such as the food industry, particularly by famous chefs and Michelin starred restaurants, the natural cosmetics industry and the food supplements industry and as a dye in the textile industry. Medicinal claims as an anti-depressant, antioxidant, and antiseptic are constantly increasing. |

---

---

| | |
|:---|:---|
| b. | The Company has an accumulated deficit in the total amount of $24,672 as of March 31, 2026, the Company has negative operating cash flow in the total amount of $73 for the three months ended March 31, 2026, further losses are anticipated in the development of its business. Those factors raise substantial doubt about the Company's ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they become due. |
|  | The Company intends to finance operating costs over the next twelve months with existing cash on hand, reducing operating spend, and future issuances of equity and debt securities, or through a combination of the foregoing. However, the Company will need to seek additional sources of financing if the Company requires more funds than anticipated during the next 12 months or in later periods.<br>|

---

---

| |
|:---|
| **SATIVUS TECH CORP**. |
| **NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** (Unaudited) |
| **U.S. dollars in thousands** |

---

---

| | |
|:---|:---|
| **NOTE 1:** | **GENERAL (cont.)** |

---

The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liabilities and commitments in the normal course of business.<br>The consolidated financial statements for the three months ended March 31, 2026, do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from uncertainty related to the Company's ability to continue as a going concern.<br>

---

| | |
|:---|:---|
| **NOTE 2:** | **SIGNIFICANT ACCOUNTING POLICIES** |

---

**Basis of Presentation and Principles of Consolidation:**

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary and were prepared in accordance with Generally Accepted Accounting Principles in the United States of America ("GAAP")

All intercompany accounts and transactions have been eliminated in the consolidation.

**Unaudited Interim Financial Information**

The Company's unaudited condensed consolidated financial statements have been prepared in accordance with GAAP and pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted from this report, as is permitted by such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited financial statements as of and for the year ended December 31, 2025, and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on April 15<sup>th</sup>, 2026 (the "2025 Annual Report"). The results for any interim period are not necessarily indicative of results for any future period.

The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited financial statements. In the opinion of the Company's management, the accompanying unaudited condensed consolidated financial statements contain all adjustments that are necessary to present fairly the Company's financial position and results of operations for the interim periods presented. The results for the three months ended March 31, 2026, are not necessarily indicative of the results for the year ending December 31, 2026, or for any future period.

As of March 31, 2026, there have been no material changes in the Company's significant accounting policies from those that were disclosed in the 2025 Annual Report.

**Fair value of financial instruments**

ASC Topic 820, "Fair Value Measurements and Disclosures" ("ASC 820"), defines fair value as the price that would be received to sell an asset or paid to transfer a liability (i.e., the "exit price") in an orderly transaction between market participants at the measurement date.

---

| |
|:---|
| **SATIVUS TECH CORP**. |
| **NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** (Unaudited) |
| **U.S. dollars in thousands** |

---

---

| | |
|:---|:---|
| **NOTE 2:** | **SIGNIFICANT ACCOUNTING POLICIES (cont.)** |

---

**Fair value of financial instruments**

ASC Topic 820, "Fair Value Measurements and Disclosures" ("ASC 820"), defines fair value as the price that would be received to sell an asset or paid to transfer a liability (i.e., the "exit price") in an orderly transaction between market participants at the measurement date.

In determining fair value, the Company uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company's assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the inputs as follows:

---

| | |
|:---|:---|
| Level 1 — | Valuations based on quoted prices in active markets for identical assets that the Company has the ability to access. |
| Level 2 — | Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly. |
| Level 3 — | Valuations based on inputs that are unobservable and significant to the overall fair value measurement. |

---

The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The carrying amounts of cash and cash equivalents, short term deposits, trade receivables, trade payables and short-term loan approximate their fair value due to the short-term maturity of such instruments.

The Company elected to measure some of the convertible loans under the fair value option. Under the fair value option the convertible loans will be measured at fair value in each reporting period until they will be converted, with changes in the fair values being recognized in the Company's consolidated statement of operations as financial income or expense. The proceeds received for the issuance of the convertible loans were allocated at fair value conducted on an arm's-length basis.

---

| |
|:---|
| **SATIVUS TECH CORP**. |
| **NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** (Unaudited) |
| **U.S. dollars in thousands** |

---

---

| | |
|:---|:---|
| **NOTE 2:** | **SIGNIFICANT ACCOUNTING POLICIES (cont.)** |

---

The Company's financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Balance as of March 31, 2026** | **Balance as of March 31, 2026** | **Balance as of March 31, 2026** | **Balance as of March 31, 2026** |
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| Liabilities: |  |  |  |  |
| Fair Value of convertible component in convertible loan, net of discounts and debt issue costs | $– | $– | $786 | 786 |
| Total liabilities | $– | $– | $786 | 786 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Balance as of December 31, 2025** | **Balance as of December 31, 2025** | **Balance as of December 31, 2025** | **Balance as of December 31, 2025** |
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| Liabilities: |  |  |  |  |
| Fair Value of convertible component in convertible loan, net of discounts and debt issue costs | $– | $– | $726 | $726 |
| Total liabilities | $– | $– | $726 | $726 |

---

**Segment Reporting**

ASC 280, "Segment Reporting," establishes standards for reporting information about operating segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker ("CODM") in deciding how to allocate resources and in assessing performance. The Company's business is comprised of one operating segment.

---

| | |
|:---|:---|
| **NOTE 3:** | **CONVERTIBLE LOANS** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. On February 21, 2019, the Company received a convertible loan from third party ("February 2019 Lender"), with a two-year term, in the principal amount of $550 , which bears 10% annual interest rate ("February 2019 Loan").

The Company, at its option, shall have the right to redeem, in part or in whole, the outstanding principal amount and interest under this loan agreement prior to the maturity date. The Company shall pay an amount equal to the principal amount being redeemed plus a redemption premium equal to 20% of the outstanding principal amount being redeemed plus outstanding and accrued interest.

The February 2019 Lender shall be entitled to convert at its option any portion of the outstanding and unpaid principal or accrued interest into fully paid and non-assessable shares of common stock, at the lower of the fixed conversion price then in effect or the market conversion price. The number of shares of common stock issuable upon conversion of any conversion amount shall be determined by dividing (x) such conversion amount by (y) the fixed conversion price of $20.00 or (z) 80% of the lowest the volume-weighted average price of the Company's shares of common stock during the 30 trading days immediately preceding the conversion date.

---

| |
|:---|
| **SATIVUS TECH CORP**. |
| **NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** (Unaudited) |
| **U.S. dollars in thousands** |

---

---

| | |
|:---|:---|
| **NOTE 3:** | **CONVERTIBLE LOANS (cont.)** |

---

The Company accounted for the February 2019 Loan in accordance with ASC 470-20, Debt with conversion and other Options. As of March 31, 2026, the BCF was revalued at $138.

On November 1, 2024, the loan agreement was extended until March 31, 2025.

The February 2019 Loan is included in the convertible loans in current liabilities as of March 31, 2026, in the amount of $426, and $422 as of December 31, 2025.

The Company accounted for the February 2019 Loan in accordance with ASC 470-20, Debt with conversion and other Options. The value of the BCF for the February 2019 Loan was calculated using Monte Carlo model. As of March 31, 2026 the Company allocated $138 to the BCF as a liability ($200 as of December 31, 2025).

As of December 31, 2025 the fair value of the conversion feature in the amount of $200 was calculated with the following parameters:

---

| | |
|:---|:---|
|  | **December 31,<br> 2025** |
| Share price | $0.12 |
| 80% of the lowest volume-weighted average price | $0.096 |

---

As of March 31, 2026 the fair value of the conversion feature in the amount of $138 was calculated with the following parameters:

---

| | |
|:---|:---|
|  | **March 31,<br> 2026** |
| Share price | $0.09 |
| 80% of the lowest volume-weighted average price | $0.068 |

---

During the three months ended March 31, 2026 the Company recorded interest expenses related to the Loan in the amount of $4.

---

| |
|:---|
| **SATIVUS TECH CORP**. |
| **NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** (Unaudited) |
| **U.S. dollars in thousands** |

---

---

| | |
|:---|:---|
| **NOTE 3:** | **CONVERTIBLE LOANS (cont.)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. On October 15, 2019, the Company received a convertible loan from a third party ("October 2019 Lender") in the principal amount of $1,100 that bears an annual 10% interest rate ("October 2019 Loan"). The October 2019 Loan had a two-year term. Prior to the maturity date of the October 2019 Loan, the Company, at its option, has the right to redeem, in cash, in part or in whole, the amounts outstanding provided that as of the date of the redemption notice (i) the volume-weighted average price of the Company's ordinary shares is less than $12.50 and (ii) there is no equity condition failures as defined therein. In the event that the Company wishes to redeem any amount under the convertible loan, the Company shall pay an amount equal to the principal amount being redeemed plus a redemption premium equal to 20% of the outstanding amount being redeemed in addition to outstanding and accrued interest.

The October 2019 Lender shall be entitled to convert the principal loan and the outstanding interest (the "Conversion Amount") into such number of ordinary shares determined by dividing (x) such Conversion Amount by (y) the fixed conversion price of $12.50 or (z) 80% of the lowest the volume-weighted average price of the Company's ordinary shares during the 10 trading days immediately preceding the conversion date.

The Company accounted for the October 2019 Loan in accordance with ASC 470-20, Debt with conversion and other Options. As of March 31, 2026, the BCF was revalued at $503.

On January 26, 2022, the Company paid accrued interest of the October 2019 Loan in the amount of $55.

On December 20, 2022, the Company paid accrued interest of the October 2019 Loan in the amount of $100, and the October 2019 Loan agreement as extended until June 30, 2023.

On January 2023, the Company paid accrued interest of the October 2019 Loan in the amount of $100.

On November 1, 2024, the loan agreement was extended until March 31, 2025.

The October 2019 Loan is included in the convertible loans in current liabilities as of March 31, 2026, in the amount of $1,556 and $1,529 as of December 31, 2025.

The Company accounted for the October 2019 Loan in accordance with ASC 470-20, Debt with conversion and other Options. The value of the BCF for the October 2019 Loan was calculated using Monte Carlo model. As of March 31, 2026 the Company allocated $503 to the BCF as a liability ($408 as of December 31, 2025).

---

| |
|:---|
| **SATIVUS TECH CORP**. |
| **NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** (Unaudited) |
| **U.S. dollars in thousands** |

---

---

| | |
|:---|:---|
| **NOTE 3:** | **CONVERTIBLE LOANS (cont.)** |

---

As of December 31, 2025 the fair value of the conversion feature in the amount of $408 was calculated with the following parameters:

---

| | |
|:---|:---|
|  | **December 31,<br> 2025** |
| Share price | $0.14 |
| 80% of the lowest volume-weighted average price | $0.112 |

---

As of March 31, 2026 the fair value of the conversion feature in the amount of $503 was calculated with the following parameters:

---

| | |
|:---|:---|
|  | **March 31,<br> 2026** |
| Share price | $0.09 |
| 80% of the lowest volume-weighted average price | $0.068 |

---

During the three months ended March 31, 2026 the Company recorded interest expenses related to the Loan in the amount of $27.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. On August 7, 2020, the Company received a convertible loan from a third party ("August 2020 Lender") in the amount of $200 (the "August 2020 Loan"). Per the terms of the Agreement, the August 2020 Loans has a maturity date of August 7, 2022, ("Maturity Date") and accrues annual interest at a rate of 10%

The August 2020 Loan is convertible by the August 2020 Lender into Shares, at their discretion, at the lower of a fixed price of $1.02 (the "Fixed Conversion Price") or 80% of the lowest volume weighted average price ("VWAP") of the Company's common stock during the 10 trading days immediately preceding the conversion date (the "Market Conversion Price").

On November 1, 2024, the loan agreement as extended until March 31, 2025.

The August 2020 Loan is included in the convertible loans in current liabilities as of March 31, 2026, in the amount of $313 and $308 as of December 31, 2025.

The Company also granted the August 2020 Investor warrants to purchase 50,000 shares of common stock of the Company at an exercise price of $2.00 per share, such exercise price is subject to any future price-based anti-dilution adjustments. In accordance with ASU 2017-11 the warrants were classified in shareholders' equity.

---

| |
|:---|
| **SATIVUS TECH CORP**. |
| **NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** (Unaudited) |
| **U.S. dollars in thousands** |

---

---

| | |
|:---|:---|
| **NOTE 3:** | **CONVERTIBLE LOANS (cont.)** |

---

The fair value of the warrants granted was $35 using the Black-Scholes-Merton option pricing model using the following assumptions:

---

| | |
|:---|:---|
|  | **August<br> 2020** |
| Share price | $0.86 |
| Dividend yield | 0% |
| Risk-free interest rate | 0.21% |
| Expected term (in years) | 5 |
| Volatility | 176.96% |

---

The Company accounted for the August 2020 Loan in accordance with ASC 470-20, Debt with conversion and other Options. The combined intrinsic value of the BCF for the August 2020 Loan was calculated and valued at $249 as of August 7, 2020, and the Company allocated $58 to the BCF as a liability. As of March 31, 2026, the BCF was revalued at $101 ($83 as of December 31, 2025).

As of December 31, 2025, The Company used an independent appraiser to estimate the fair value of BCF which used the Monte Carlo option pricing model using the following weighted average assumptions:

---

| | |
|:---|:---|
|  | **August 7,<br> 2020** |
| Share price | $0.80 |
| Dividend yield | 0% |
| Risk-free interest rate | 0.13% |
| Expected term (in years) | 2 |
| Volatility | 163.31% |

---

As of December 31, 2025 the fair value of the conversion feature in the amount of $82 was calculated with the following parameters:

---

| | |
|:---|:---|
|  | **December 31,<br> 2025** |
| Share price | $0.14 |
| 80% of the lowest volume-weighted average price | $0.112 |

---

As of March 31, 2026 the fair value of the conversion feature in the amount of $101 was calculated with the following parameters:

---

| | |
|:---|:---|
|  | **March 31,<br> 2026** |
| Share price | $0.09 |
| 80% of the lowest volume-weighted average price | $0.068 |

---

During the three months ended March 31, 2026 the Company recorded interest expenses related to the Loan in the amount of $5.

---

| |
|:---|
| **SATIVUS TECH CORP**. |
| **NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** (Unaudited) |
| **U.S. dollars in thousands** |

---

---

| | |
|:---|:---|
| **NOTE 3:** | **CONVERTIBLE LOANS (cont.)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. On July 31, 2020, the Company received a convertible loan from Mr. Shmuel Yannay (a third party at that time, and a director of the Company as of October 28, 2021) in the amount of $100 ("Director Loan"). The loan has a maturity date of July 31, 2022 ("Maturity Date") and accrues annual interest at a rate of 10%.

The Director Loan is convertible into Shares, at his discretion, at the lower of a fixed price of $1.02 (the "Fixed Conversion Price") or 80% of the lowest volume weighted average price ("VWAP") of the Company's common stock during the 10 trading days immediately preceding the conversion date (the "Market Conversion Price").

The Company also granted the Mr. Yannay warrants to purchase 25,000 shares of common stock of the Company at an exercise price of $2.00 per share, such exercise price is subject to any future price-based anti-dilution adjustments. Accordance with ASU 2017-11 the warrants were classified in shareholders equity.

The fair value of the warrants granted was $18 using the Black-Scholes-Merton option pricing model using the following assumptions:

---

| | |
|:---|:---|
|  | **August<br> 2020** |
| Share price | $0.86 |
| Dividend yield | 0% |
| Risk-free interest rate | 0.21% |
| Expected term (in years) | 5 |
| Volatility | 176.96% |

---

On November 1, 2024, the loan agreement was extended until March 31, 2025.

The Director Loan is included in the convertible loans in current liabilities as of March 31, 2026, in the amount of $135 and $132 as of December 31, 2025.

The Company accounted for the director's loan in accordance with ASC 470-20, Debt with conversion and other Options. The combined intrinsic value of the BCF for the August 2020 Loan was calculated and valued at $129 as of July 31, 2020, and the Company allocated $129 to the BCF as a liability. As of March 31, 2026, the BCF was revalued at $44 ($35 as of December 31, 2025).

---

| |
|:---|
| **SATIVUS TECH CORP**. |
| **NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** (Unaudited) |
| **U.S. dollars in thousands** |

---

---

| | |
|:---|:---|
| **NOTE 3:** | **CONVERTIBLE LOANS (cont.)** |

---

As of December 31, 2025 the fair value of the conversion feature in the amount of $35 was calculated with the following parameters:

---

| | |
|:---|:---|
|  | **December 31,<br> 2025** |
| Share price | $0.14 |
| 80% of the lowest volume-weighted average price | $0.112 |

---

As of March 31, 2026 the fair value of the conversion feature in the amount of $44 was calculated with the following parameters:

---

| | |
|:---|:---|
|  | **March 31,<br> 2026** |
| Share price | $0.09 |
| 80% of the lowest volume-weighted average price | $0.068 |

---

During the three months ended March 31, 2026, the Company recorded interest expenses related to Director Loan in the amount of $3.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. On March 2024 the Company received $36 convertible loan from third party. The loan is convertible at a conversion ratio of $1 per share.

---

| | |
|:---|:---|
| **NOTE 4:** | **RELATED PARTIES** |

---

The following transactions arose with related parties:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | |
|  | **Directors<br> Fees** | **Consulting<br> Fees / Salaries** | **Interests** | **Total** | **Amounts owing**<br>**by (to) as of<br> March 31,<br> 2026** |
| CFO | $– | $8 | $– | $8 | $(11) |
| Company controlled by CFO |  | 8 |  | 8 | (9) |
| Director and CEO |  | 51 |  | 51 | (148) |
| Directors | – | – | 3 | 3 | (272) |
|  | $– | $67 | $3 | $70 | $(440) |

---

---

| |
|:---|
| **SATIVUS TECH CORP**. |
| **NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** (Unaudited) |
| **U.S. dollars in thousands** |

---

---

| | |
|:---|:---|
| **NOTE 4:** | **RELATED PARTIES (cont.)** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | |
|  | **Directors<br> Fees** | **Consulting<br> Fees / Salaries** | **Other<br> Expenses** | **Total** | **Amounts owing**<br>**by (to) as of<br> March 31,<br> 2025** |
| CFO | $– | $7 | $– | $7 | $– |
| Company controlled by CFO |  | 8 |  | 8 | (22) |
| Directors | – | – | 3 | 3 | (153) |
|  | $– | $15 | $3 | $18 | $(175) |

---

---

| | |
|:---|:---|
| A | The Company signed an agreement with the CFO, effective December 1, 2023, pursuant to which the CFO received $3 per month for his services. Amounts owed to the CFO as of March 31, 2026, were $7. |
| B. | The Company signed an agreement with the newly CEO of Saffron Tech, effective November 1, 2024, pursuant to which the newly appointed CEO will receive NIS54 per month. Amounts owed to the CEO as of March 31, 2026, were $51. |

---

---

| | |
|:---|:---|
| **NOTE 5:** | **SHAREHOLDERS' DEFICIT** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. As of March 31, 2026 and December 31, 2025, the Company's share capital is composed as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **March 31,<br> 2026** | **March 31,<br> 2026** | **December 31,<br> 2025** | **December 31,<br> 2025** |
|  | **Authorized** | **Issued and<br> outstanding** | **Issued and<br> outstanding** | **Issued and<br> outstanding** |
|  | **Number of shares** | **Number of shares** | **Number of shares** | **Number of shares** |
| Shares of common stock of $0.0001 par value each "Shares" | 500000000 | 4215571 | 500000000 | 4215571 |

---

Each Ordinary share is entitled to receive dividend, participate in the distribution of the Company's net assets upon liquidation and to receive notices of participate and vote (at one vote per share) at the general meetings of the Company on any matter upon which the general meeting is authorized.

On December 9, 2021, we implemented a 1-for-10 consolidation, or reverse split, of our issued and outstanding common shares. Except where otherwise indicated, all share and per share data in these financial statements have been retroactively restated to reflect the reverse stock split.

---

| |
|:---|
| **SATIVUS TECH CORP**. |
| **NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** (Unaudited) |
| **U.S. dollars in thousands** |

---

---

| | |
|:---|:---|
| **NOTE 5:** | **SHAREHOLDERS' DEFICIT (cont.)** |

---

b. Warrants <br>A summary of warrant activity during the three months period ended March 31, 2026, and year ended December 31, 2025 is as follows:

---

| | | |
|:---|:---|:---|
|  | **Number** | **Average<br> exercise<br> price** |
| Warrants outstanding at January 1, 2025 | 75000 | $2 |
| &nbsp;&nbsp;&nbsp;Expired | (75000) | 2 |
| Warrants outstanding at December 31, 2025 | – | – |
| &nbsp;&nbsp;&nbsp;Expired |  |  |
| Warrants outstanding at March 31, 2026 | – | $– |

---

---

| | |
|:---|:---|
|  | There were not any warrants outstanding as of March 31, 2026 and December 31, 2025. |
| c. | Share option plans: |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; On April 1, 2019, the Company's board of directors adopted the Sativus Tech Corp. 2018 Share Options Plan (the "2018 Plan").<br>Awards granted under the 2018 Plan are subject to vesting schedules and unless determined otherwise by the administrator of the 2018 Plan, generally vest following a period of four years from the applicable vesting commencement date, such that the awards vest in four annual equal instalments and/or generally vest following a period of one year from the applicable vesting commencement date, such that the awards vest in four quarterly equal instalments.<br>|

---

---

| |
|:---|
| **SATIVUS TECH CORP**. |
| **NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** (Unaudited) |
| **U.S. dollars in thousands** |

---

---

| | |
|:---|:---|
| **NOTE 5:** | **SHAREHOLDERS' DEFICIT (cont.)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) A summary of employee share options activity during the three month ended March 31, 2026, and the year ended December 2025 is as follows:

---

| | | |
|:---|:---|:---|
|  | **Number** | **Average weighted exercise price** |
| Options outstanding at January 1, 2025 | 65000 | $1.12 |
| &nbsp;&nbsp;&nbsp;Exercised | (65000) | 1.12 |
| Options outstanding at December 31, 2025 |  |  |
| &nbsp;&nbsp;&nbsp;Exercised | – | – |
| Options exercisable at March 31, 2026 | – | $– |

---

There were not any options outstanding as of March 31, 2026 and December 31, 2025:

---

| | |
|:---|:---|
| d. | Restricted Share Units: |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RSUs under the 2018 Plan may be granted upon such terms and conditions, no monetary payment (other than payments made for applicable taxes) shall be required as a condition of receiving the Company's shares pursuant to a grant of RSUs, and unless determined otherwise by the Company, the aggregate nominal value of such RSUs shall not be paid and the Company shall capitalize applicable profits or take any other action to ensure that it meets any requirement of applicable laws regarding issuance of shares for consideration that is lower than the nominal value of such shares. If, however, the Company's board of directors determines that the nominal value of the shares shall not be waived and shall be paid by the grantees, then it shall determine procedures for payment of such nominal value by the grantees or for collection of such amount from the grantees by the Company.<br>|

---

---

| |
|:---|
| **SATIVUS TECH CORP**. |
| **NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** (Unaudited) |
| **U.S. dollars in thousands** |

---

---

| | |
|:---|:---|
| **NOTE 5:** | **SHAREHOLDERS' DEFICIT (cont.)** |

---

Shares issued pursuant to any RSUs units may (but need not) be made subject to exercise conditions, as shall be established by the Company and set forth in the applicable notice of grant evidencing such award. During any restriction period in which shares acquired pursuant to an award of RSUs remain subject to exercise conditions, such shares may not be sold, exchanged, transferred, pledged, assigned or otherwise disposed of unless otherwise provided in the 2018 Plan. Upon request by the Company, each grantee shall execute any agreement evidencing such transfer restrictions prior to the receipt of shares hereunder and the Company may place appropriate legends evidencing any such transfer restrictions on the relevant share certificates.<br>A summary of RSU activity during the three months ended March 31, 2026, and the year ended December 31, 2025 is as follows:<br>

---

| | |
|:---|:---|
|  | **Number** |
| RSU outstanding at January 1, 2025 | 531000 |
| &nbsp;&nbsp;&nbsp;Granted | **–** |
| &nbsp;&nbsp;&nbsp;Forfeited | **–** |
| RSU's outstanding at December 31, 2025 | 531000 |
| &nbsp;&nbsp;&nbsp;Forfeited | – |
| RSU's exercisable at March 31, 2026 | 531000 |

---

---

| | |
|:---|:---|
| **NOTE 6:** | **FINANCIAL INCOME (EXPENSES)** |

---

---

| | | |
|:---|:---|:---|
|  | **Three months<br> ended**<br>**March 31,**<br>**2026** | **Three months<br> ended**<br>**March 31,**<br>**2025** |
| Financial Income (expenses) related to revaluation of convertible component in convertible loans | $(100) | $203 |
| Bank interest and commissions |  | (43) |
| Foreign currency transactions and other | (4) | 2 |
|  | $(104) | $162 |

---

---

| |
|:---|
| **SATIVUS TECH CORP**. |
| **NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** (Unaudited) |
| **U.S. dollars in thousands** |

---

---

| | |
|:---|:---|
| **NOTE 7:** | **LIENS, COMMITMENTS** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Saffron leases its facilities on leases that expired on December 15, 2024 . Lease payments are approximately $5 per month ($60 annually). Saffron has the option to extend the lease period for two additional option periods of 12 months each (first option from 16.12.2024 to 15.12.2025 and second option from 16.12.2025 to 15.12.2026). Saffron did not extend the lease for a set amount of time but rather pay for each month they use the facilities.

b. Saffron Tech is committed to pay royalties to the IIA on the proceeds from sales of products resulting from research and development projects in which the IIA participates by way of grants. In the first 3 years of sales the Company shall pay 3% of the sales of the product which was developed under IIA research and development projects. In the fourth, fifth and sixth years of sales, the Company shall pay 4% of such sales and from the seventh year onwards the Company shall pay 5% of up to 100% of the amount of grants received plus interest at LIBOR. Saffron Tech was entitled to the grants only upon incurring research and development expenditures. There were no future performance obligations related to the grants received from the IIA. As of December 31, 2025, the contingent liabilities with respect to grants received from the IIA, subject to repayment under these royalty agreements on future sales is $Nil. As of December 31, 2025, Saffron Tech received a total of $452 from the IIA

c. The Company's holdings in Saffron Tech are secured to a third party until such time that the third-party convertible loans have been extinguished.

---

| | |
|:---|:---|
| **NOTE 8:** | **SUBSEQUENT EVENTS** |

---

In accordance with ASC 855-10, Company management reviewed all material events through the date of this report and determined that there are no additional material subsequent events to report.

**Item 1C. Cybersecurity**

We recognize the critical importance of developing, implementing, and maintaining robust cybersecurity measures to safeguard our information systems and protect the confidentiality, integrity, and availability of our data. We currently have security measures in place to protect our clients, customers, employees, and vendor information and prevent data loss and other security breaches. We also only use third party software for accounting, billing and payroll that have successful SOC 1 type 2 compliance. Both management and the Board are actively involved in the continuous assessment of risks from cybersecurity threats, including prevention, mitigation, detection, and remediation of cybersecurity incidents.

Our current cybersecurity risk assessment program consists of an annual review of our risks and policies. The program outlines governance, policies and procedures, and technology we use to oversee and identify risks from cybersecurity threats.

Our CEO is responsible for overseeing our business operations and are responsible for day-to-day assessment and management of risks from cybersecurity threats, including the prevention, mitigation, detection, and remediation of cybersecurity incidents. We also use the services of an outside consulting firm to monitor activity and advise the company of cybersecurity protocols.

We routinely undertake activities to prevent, detect, and minimize the effects of cybersecurity incidents, including an annual risk review, policy reviews and revisions. In addition, we maintain business continuity, contingency, and recovery plans for use in the event of a cybersecurity incident by the administering of local and cloud based back up of files. and emails.

We engaged and used the advice of a third-party consultant to help us assess and identify risks from cybersecurity threats, including the threat of a cybersecurity incident, and manage our risk assessment program. Among other things, these providers have recommended periodic evaluations of the work stations.

We have multiple controls in place in order to prevent breaches, some of these controls include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. FMA/2FA, this is our first AND most important first line of defense, no one should have MFA bypassed or disabled, with no exceptions.

b. Email Banner for external emails. This banner assists us to identify any phishing / impersonation email and cannot be bypassed.

c. Conditional Access Policy (CAP): Rejects connections to Exchange Online from un-authorized countries. We are further enhancing this control by implementing ACL's (access lists) in our CRM and ERP systems and any other mission critical platform. ALL platforms should have MFA enforced, any platform not supporting MFA in 2024 is deemed high-risk and immediately replaced as it is obsolete and poses high-risk to the Company.

As of the date of this report, no cybersecurity incident (or aggregation of incidents) or cybersecurity threat has materially affected our results of operations or financial condition. However, an actual or perceived breach of our security could damage our reputation and cause damage to our relationships, , as well as prevent us from attracting new clients / customers. and / or subject us to third-party lawsuits, regulatory fines or other actions or liabilities, any of which could adversely affect our business, operating results or financial condition. We currently do not carry a cyber liability insurance policy, but are evaluating whether to acquire one to mitigate any financial impact of a cybersecurity breach.

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.**

THE FOLLOWING DISCUSSION SHOULD BE READ IN CONJUNCTION WITH OUR AUDITED FINANCIAL STATEMENTS AND THE RELATED NOTES THAT APPEAR ELSEWHERE IN THIS QUARTERLY REPORT ON FORM 10-Q AND THE FINANCIAL STATEMENTS AND RELATED NOTES THERETO FOR THE FISCAL YEAR ENDED DECEMBER 31, 2025 AND THE RELATED MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, BOTH OF WHICH ARE CONTAINED IN OUR ANNUAL REPORT ON FORM 10-K FILED WITH THE SECURITIES AND EXCHANGE COMMISSION (THE "SEC"), ON MARCH 31, 2026. PAST OPERATING RESULTS ARE NOT NECESSARILY INDICATIVE OF RESULTS THAT MAY OCCUR IN FUTURE PERIODS. THE FOLLOWING DISCUSSION CONTAINS FORWARD-LOOKING STATEMENTS THAT REFLECT OUR PLANS, ESTIMATES AND BELIEFS. OUR ACTUAL RESULTS COULD DIFFER MATERIALLY FROM THOSE DISCUSSED IN THE FORWARD-LOOKING STATEMENTS. FACTORS THAT COULD CAUSE OR CONTRIBUTE TO SUCH DIFFERENCES INCLUDE THOSE DISCUSSED BELOW AND ELSEWHERE IN THIS QUARTERLY REPORT.

**FORWARD-LOOKING STATEMENTS**

When used in this quarterly report, the terms "Sativus," "the Company," "we," "our," and "us" refer to SATIVUS TECH CORP., a Delaware corporation, unless otherwise indicated or as otherwise required by the context.

**Company Overview**

SATIVUS TECH CORP. (formerly SEEDO CORP.) (the "Company", "Our" or "We") was formed on January 16, 2015, under the laws of the State of Delaware. Prior to July 2020, we were involved in producing a plant growing device managed and controlled by an artificial intelligent algorithm, allowing consumers to grow their own herbs and vegetables effortlessly from seed to plant, while providing optimal conditions to assure premium quality produce year-round. However, due to financial and operational difficulties and during 2020, we ceased these operations and on July 19, 2020, the Company formed a new wholly-owned subsidiary in Israel, Hachevra Legiduley Pkaot Beisrael Ltd. (the "New Subsidiary"), to develop a fully automated and remotely managed system for growing saffron and other vegetables. On November 5, 2020, the New Subsidiary changed its name to Saffron-Tech Ltd. (or "Saffron Tech"). As of the date of this report, and following various financings in Saffron Tech, the Company owns 54% of Saffron Tech.

The Company, through Saffron Tech, is focusing on its in-house research and development of agriculture technology products, among others, in the fields of exotic plants and mushrooms. Saffron Tech plans to roll out its proof of concept in the coming months. This technology will provide turnkey automated growing containers for high-quality, high-yield saffron all year round. The Company is in advanced stages of developing and testing a fully automated and remotely managed system for growing high-quality, high-yield saffron anywhere and anytime.

It is also environmentally friendly, using economic levels of water, space, fertilizer, and energy. Accounting to the Company's calculations, we believe that the controlled indoor growing area will produce ten times more yield compared to the same land area using traditional methods. The sealed environment eliminates the need for harmful pesticides and herbicides, producing a clean and safe product that is easy to control from anywhere. The Company's solution is easily scalable and pre-designed to quickly grow operations.

Saffron is used in many industries, such as the food industry, particularly by famous chefs and Michelin starred restaurants, the natural cosmetics industry and the food supplements industry and as a dye in the textile industry. Medicinal claims as an anti-depressant, antioxidant, and antiseptic are constantly increasing.

On January 6, 2022, the Company announced that its subsidiary, Saffron Tech, has planted approximately 25,000 Saffron bulbs in fields in the Golan Heights, in Norther Israel. The plantation is being managed in conjunction with the Shamir Research Institute.

On April 4, 2022, the Company announced that Mr. Moshe Bar Siman Tov and Mrs. Iris Tova Ginsburg have resigned from the Board of Directors of the Company, and immediate appointed Mrs. Tal Wilk-Glazer to its Board of Directors and as CEO of the Company.

In April 2022, Saffron Tech announced its new state-of-the-art indoor research and development center is operational. From April 2022, through to December 2022, Saffron Tech successfully completed three Saffron cultivation cycles using vertical farming technology, while traditional agriculture only produces one harvest of saffron per year.

On August 30, 2022, Saffron Tech, announced its intention to raise up to 5 million New Israeli Shekels ("NIS") (approximately $1.5 million) at a pre-money valuation of NIS 32.5 million (approximately $10 million) through the Israeli crowdfunding platform – Pipelbiz ("2022 Crowd Funding Round"). Assuming the maximum amount is raised, the Company will own approximately 61% of Saffron Tech. The 2022 Crowd Funding Round was closed on December 1, 2022, having raised 3.8 million NIS (approximately $1.3 million). Fundraising expenses accumulated to $152 and the net amount raised through Pipelbiz was $1.15 million. Saffron Tech also raised 1.15 million NIS (approximately $328 thousand) through the issuance of SAFEs. The SAFEs are convertible at a 20% discount to the current crowdfunding round. Sativus Tech's interest in Saffron Tech now totals 67.5% post-raise. All SAFEs were converted before December 31, 2022. Saffron Tech continued to raise funds through Pipelbiz under the same pre-money valuation from December 2022 through to January 2023, via another crowdfunding round "2023 Crowd Funding Round" which closed on February 5, 2023, having raised another 1.1 million NIS (approximately $314 thousand).

On March 1, 2023, Saffron Tech entered into an investment agreement with Korean-based company, Dreamtech Co Ltd ("Dreamtech"), a leading provider and manufacturer of tech components for innovative products including advanced mobile and medical devices. Under this new agreement, Dreamtech will fund an initial investment of $1 million followed by an additional $1 million upon a successful cultivation of saffron in Korea. On March 5<sup>th</sup> Dreamtech officially announced a successful completion of the POC for Saffron cultivation in Korea, while meeting the defined success measurements for saffron quantity and saffron quality.

Saffron Tech aims to be the first company to create a large-scale production of saffron using vertical farming technology to meet the growing demand of the spice for use in beauty, wellness, and pharmaceutical applications. Sativus Tech's interest in Saffron Tech now totals 54% post-raise.

On May 9, 2024, Saffron Tech launched a pilot site in Ganei Tal, Israel. The pilot demonstrates commercial-like Saffron cultivation, using Saffron Tech proprietary technology and growth protocol.8j0. In the pilot site Saffron Tech will grow more than 12,000 corms in parallel, 4 cycles a year. The company invested $290. The Israeli innovation authority ("IIA") participation was $250.

On October 28<sup>th</sup>, 2024, the Board appointed Board Member and Director Shmulik Yannay as CEO of the Company. On the same day Tal Wilkes Glazer resigned her position as Director, CEO & Board Member. Her resignation was not the result of any dispute with the Company.

On October 20<sup>th</sup>, 2025, the Board appointed Board Member and Director Michael Oster as CEO of the Company. On the same day Shmulik Yannay resigned his position as Director, CEO & Board Member. His resignation was not the result of any dispute with the Company.

***Basis of Presentation***

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial statement presentation and in accordance with Form 10-Q. Accordingly, they do not include all of the information and footnotes required in annual financial statements. In the opinion of management, the unaudited condensed financial statements contain all adjustments (consisting only of normal recurring accruals) necessary to present fairly the financial position and results of operations and cash flows. The results of operations presented are not necessarily indicative of the results to be expected for any other interim period or for the entire year.

These unaudited condensed financial statements should be read in conjunction with our December 31, 2025, annual financial statements included in our Form 10-K, filed with the SEC on April 15<sup>th</sup>, 2026.

***Going Concern***

Due to the uncertainty of our ability to meet our current operating and capital expenses, our independent auditors included an explanatory paragraph in their report on the condensed consolidated financial statements for the three months ended March 31, 2026, regarding concerns about our ability to continue as a going concern. Our financial statements contain additional note disclosures describing the circumstances that lead to this disclosure by our independent auditors.

Our unaudited condensed financial statements have been prepared on a going concern basis, which assumes the realization of assets and settlement of liabilities in the normal course of business. Our ability to continue as a going concern is dependent upon our ability to generate profitable operations in the future and/or to obtain the necessary financing to meet our obligations and repay our liabilities arising from normal business operations when they become due. The outcome of these matters cannot be predicted with any certainty at this time and raise substantial doubt that we will be able to continue as a going concern. Our unaudited condensed financial statements do not include any adjustments to the amount and classification of assets and liabilities that may be necessary should we be unable to continue as a going concern. There is no assurance that our operations will be profitable. Our continued existence and plans for future growth depend on our ability to obtain the additional capital necessary to operate either through the generation of revenue or the issuance of additional debt or equity.

**Financing**

We will require additional financing to implement our business plan, which may include joint venture projects and debt or equity financings. The nature of this enterprise and constraint of positive cash flow places debt financing beyond the credit-worthiness required by most banks or typical investors of corporate debt until such time as an economically viable profits and losses can be demonstrated. Therefore, any debt financing of our activities may be costly and result in substantial dilution to our stockholders.

Future financing through equity investments is likely to be dilutive to existing stockholders. Also, the terms of securities we may issue in future capital transactions may be more favorable for our new investors. Newly issued securities may include preferences, superior voting rights, and the issuance of warrants or other derivative securities, which may have additional dilutive effects. Further, we may incur substantial costs in pursuing future capital and financing, including investment banking fees, legal fees, accounting fees, and other costs. We may also be required to recognize non-cash expenses in connection with certain securities we may issue, such as convertible notes and warrants, which will adversely impact our financial condition.

Our ability to obtain needed financing may be impaired by such factors as the capital markets, both generally and specifically in the Agro-tech industry, which could impact the availability or cost of future financings. If the amount of capital we are able to raise from financing activities, together with our revenue from operations, is not sufficient to satisfy our capital needs, even to the extent that we reduce our operations accordingly, we may be required to cease operations.

There is no assurance that we will be able to obtain financing on terms satisfactory to us, or at all. We do not have any arrangements in place for any future financing. If we are unable to secure additional funding, we may cease or suspend operations. We have no plans, arrangements or contingencies in place in the event that we cease operations.

**Results of Operations**

**<u>Three months ended March 31, 2026 compared to the three months ended March 31, 2025</u>**

<u>Operating Expenses</u>

Research and development expenses for the three months ended March 31, 2026, were $77 thousand compared to $206 thousand for the same period in 2025.

General and administrative ("G&A") expenses for the three months ended March 31, 2026, were $71 thousand compared to $54 thousand for the same period in 2025.

Total financial expenses for the three months ended March 31, 2026, was $104 compared to $162 thousand income for the same period in 2025. Financial income is due to Financial expenses and income related to revaluations of the convertible component in convertible loans.

**Liquidity and Capital Resources**

***Overview***

Since inception on January 16, 2015, the Company has a cumulative deficit of $24,672 thousand and a working capital deficit of $3,970 thousand as of March 31, 2026. Our future growth is dependent upon achieving further purchase orders and execution, management of operating expenses and ability of the Company to obtain the necessary financing to fund future obligations, and upon profitable operations. Those factors raise substantial doubt about the Company's ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they become due.

Historically, we have financed our cash flow and operations from the initial contribution of our majority shareholder and by raising equity and convertible loans and warrants.

We had a negative working capital of $3,970 thousand and $3,735 thousand as of March 31, 2026, and December 31, 2025, respectively.

During the three months ended March 31, 2026, we had negative cash flow from operations of $73 thousand which was mainly the result of a net loss of $252 thousand, and financial expenses related to revaluations of convertible component in convertible loans in the amount of $60 thousand and changes in assets and liabilities of $61 thousand, depreciation of $17 thousand, and financial expenses related to convertible loans and warrants of $41 thousand. Cash flow from operation activity in the three months ended March 31, 2025, was the result of a net loss of $98 thousand, and financial gains from revaluations of convertible component in convertible loans in the amount of $203 thousand offset by changes in assets and liabilities of $14 thousand, depreciation of $95 thousand, and financial expenses related to convertible loans and warrants of $42 thousand.

During the three months ended March 31, 2026, we had positive cash flow from investment of $2 thousand compared to a positive cash flow of $6 thousand for the same period in 2025. The positive investing cash flow was primarily the result of a decrease in restricted cash.

During the three months ended March 31, 2026, we had positive cash flow from financing activities of $39 compared to a positive cash flow from financing activities during the three months ended March 31, 2025 of $80 thousand. The positive investing cash flow during the three months ended March 31, 2026 was primarily the result of proceeds from related parties' loan. The positive investing cash flow during the three months ended March 31, 2025 was primarily the result of proceeds from related parties' loan, convertible loan and from issuance of shares to minority interests in subsidiary.

**Item 3. Quantitative and Qualitative Disclosures about Market Risk**

We are a smaller reporting company as defined in Rule 12b-2 of the Exchange Act of 1934, as amended (the "Exchange Act") and are not required to provide the information required under this item.

**Item 4. Controls and Procedures**

**Evaluation of Disclosure Controls and Procedures**

In connection with the preparation of our Quarterly Report on Form 10-Q, an evaluation was carried out by management, with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of March 31, 2026. Disclosure controls and procedures are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

During evaluation of disclosure controls and procedures as of March 31, 2026, conducted as part of our preparation of the quarterly unaudited condensed financial statements, management, including our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of the design and operations of our disclosure controls and procedures and concluded that our disclosure controls and procedures were not effective.

**Changes in Internal Control Over Financial Reporting**

As of the end of the period covered by this report, there have been no changes in internal control over financial reporting that materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

**Part II - Other Information**

**Item 5. Other Information**

During the quarter ended March 31, 2026, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

**Item 6. Exhibits**

---

| | |
|:---|:---|
| **Exhibit<br> Number** | **Description** |
| 10.1 | [Form of Subscription Agreement](http://www.sec.gov/Archives/edgar/data/1661600/000117891319001020/exhibit_10-1.htm) (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on April 2, 2019). |
| 31.1\* | [Rule 13a-14(a) Certification of the Chief Executive Officer](sativus_ex3101.htm) |
| 31.2\* | [Rule 13a-14(a) Certification of the Chief Financial Officer](sativus_ex3102.htm) |
| 32.1\*\* | [Section 1350 Certification of Chief Executive Officer](sativus_ex3201.htm) |
| 32.2\*\* | [Section 1350 Certification of Chief Financial Officer](sativus_ex3202.htm) |
| 101.INS | Inline XBRL Instance Document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |

---

\* Filed herewith. <br>\*\* Furnished herewith.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated.

---

| | | |
|:---|:---|:---|
| Dated: May 14, 2026 | By: | */s/ Michael Oster* |
|  |  | *Michael Oster* |
|  |  | Chief Executive Officer |
|  |  | SATIVUS TECH CORP. |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF**

**THE SARBANES-OXLEY ACT OF 2002**

I, *Michael Oster*, certify that:

1. I have reviewed this Form 10-Q of SATIVUS TECH CORP.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: May 14, 2026 | By: | */s/ Michael Oster* |
|  |  | *Michael Oster* |
|  |  | Director, Chief Executive Officer<br> SATIVUS TECH CORP. |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF**

**THE SARBANES-OXLEY ACT OF 2002**

I, Uri Ben-Or, certify that:

1. I have reviewed this Form 10-Q of SATIVUS TECH CORP.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: May 14, 2026 | By: | */s/ Uri Ben-Or* |
|  |  | Uri Ben-Or |
|  |  | Chief Financial Officer<br> SATIVUS TECH CORP. |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION OF**

**PRINCIPAL EXECUTIVE OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF**

**THE SARBANES-OXLEY ACT OF 2002**

In connection with this Quarterly Report of SATIVUS TECH CORP. (the "Company") on Form 10-Q for the quarter ending March 31, 2026, as filed with the U.S. Securities and Exchange Commission on the date hereof (the "Report"), I, *Michael Oster*, Director and Chief Executive Officer (Principal Executive Officer) of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

1. Such Quarterly Report on Form 10-Q for the quarter ending March 31, 2026, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in such Quarterly Report on Form 10-Q for the quarter ending March 31, 2026, fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: May 14, 2026 | By: | */s/ Michael Oster* |
|  |  | *Michael Oster* |
|  |  | Director, Chief Executive Officer<br> SATIVUS TECH CORP. |

---

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION OF**

**PRINCIPAL FINANCIAL OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF**

**THE SARBANES-OXLEY ACT OF 2002**

In connection with this Quarterly Report of SATIVUS TECH CORP. (the "Company") on Form 10-Q for the quarter ending March 31, 2026, as filed with the U.S. Securities and Exchange Commission on the date hereof (the "Report"), I, Uri Ben-Or, Chief Financial Officer (Principal Financial Officer) of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

1. Such Quarterly Report on Form 10-Q for the quarter ending March 31, 2026, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in such Quarterly Report on Form 10-Q for the quarter ending March 31, 2026, fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: May 14, 2026 | By: | */s/ Uri Ben-Or* |
|  |  | Uri Ben-Or |
|  |  | Chief Financial Officer<br> SATIVUS TECH CORP. |

---